Brian Schwartz

V.P. Chief Medical Officer, ZIOPHARM Oncology.

Companies

CyclacelInterim Chief Medical Officer Jan 31, 2024 to Jan 31, 2024¹
CyclacelBoard member Dec 21, 2020 to Jan 31, 2024²
INFINITY PHARMACEUTICALS, INC.Board member Sep 10, 2021 to Jun 16, 2022³
Vincerx Pharma, Inc.Board member Mar 9, 2020 to Mar 9, 2020⁴
ZIOPHARM OncologyV.P. Chief Medical Officer Apr 2, 2008 to Apr 2, 2008⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cyclacel BGMS15,205 shares⁶$14.0K at $0.92Jan 29, 2024
INFINITY PHARMACEUTICALS, INC.30,919 shares⁷Jun 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 29, 2024Granted 12,500 shares of Cyclacel⁶
Jun 30, 2023Granted 21,219 shares of Cyclacel⁸
Jun 16, 2022Granted 30,919 shares at $0.68 of INFINITY PHARMACEUTICALS, INC.⁷
Jun 14, 2022Granted 15,822 shares of Cyclacel⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCyclacel, Interim Chief Medical Officer
2
SEC EDGARCyclacel, Board member
3
SEC EDGARINFINITY PHARMACEUTICALS, INC., Board member
4
SEC EDGARVincerx Pharma, Inc., Board member
5
SEC EDGARZIOPHARM Oncology, V.P. Chief Medical Officer
6
SEC EDGARCyclacel shares after the filing of Jan 29, 2024
7
SEC EDGARINFINITY PHARMACEUTICALS, INC. shares after the filing of Jun 16, 2022
8
SEC EDGARForm 4 filed Jul 3, 2023
9
SEC EDGARForm 4 filed Jun 16, 2022